Skip to main content
Fig. 2 | BMC Ophthalmology

Fig. 2

From: Efficacy of combining intravitreal injections of ranibizumab with micropulse diode laser versus intravitreal injections of ranibizumab alone in diabetic macular edema (ReCaLL): a single center, randomised, controlled, non-inferiority clinical trial

Fig. 2

a - Boxplot for BCVA (best corrected visual acuity) measured with ETDRS charts (ITT, n = 19); no statistically significant difference could be observed between the groups at baseline (V1), after the upload phase (V5) and at the end of treatment (V14); BCVA values expressed in ETDRS charts; b - Boxplot for CMT (central macular thickness; μm; ITT, n = 19); no statistically significant difference could be observed between the groups at baseline (V1), after the upload phase (V5) and at the end of treatment (V14)

Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us